Quanterix Accelerator Laboratory Gains New York State Clinical Lab Permit
The CLIA-certified facility is now authorized to operate in all 50 states, expanding biomarker testing capabilities nationwide.
The CLIA-certified facility is now authorized to operate in all 50 states, expanding biomarker testing capabilities nationwide.
COLA Inc. announces that its Pathology Accreditation Program has been approved in the State of California.
The Association for Molecular Pathology and the Association of Pathology Chairs have voiced their support for the Verified Innovative Testing in American Laboratories (VITAL) Act of 2021.
Updates include new criteria in the areas of immunohematology, transfusion services, and mass spectrometry.
Read MoreHNL underwent a rigorous onsite inspection, including verification of the academic and professional qualifications of the laboratory’s management team, personnel training, specimen handling, analytical procedures, and quality assurance program.
Read MoreThe International Society for Cell and Gene Therapy is leading a global consortium to oppose unproven cell therapies and services in the cell and gene sector.
Read MoreFour leading health organizations join more than 50 prominent groups in healthcare and patient advocacy.
Read MoreThe renewal applies to specialties that include clinical chemistry, diagnostic immunology, hematology, immunohematology, and microbiology.
Read MoreCOLA has requested that GAO expand its recent report on the implementation of reimbursement rate cuts to Medicare’s clinical laboratory fee schedule.
Read MoreThe ImmunoPrism assay enables in-house, RNA-based, solid tumor profiling, and supplies powerful, Cloud-based informatics tools to inform clinical decisions.
Read MoreThe former CEO of Clinical Pathology Laboratories, Stratton brings extensive experience in the importance of laboratory medicine to patient care.
Read MoreCOLA invites labs to participate in a new impact survey on how PAMA cuts to Medicare reimbursement rates are affecting laboratory services.
Read MoreWhile both BNP and N-Terminal Pro-BNP are excellent markers of cardiac failure, it is important to understand wherein the analyses and metabolism differ.
Read MoreLab accreditation organization COLA has issued a statement in response to the recent publication of final clinical lab fees for 2018 by the Centers for Medicare and Medicaid Services.
Read MoreEurofins Genomics has received CAP accreditation and CLIA certification for its new laboratory in Louisville, Ky,
Read MoreAccording to the accreditor, laboratorians are uniquely positioned to help reduce adverse patient outcomes.
Read MoreThe AABB/A2LA accreditation program will work in partnership with clinical laboratories, blood banks, and transfusion services to foster a culture of ongoing improvement and innovation.
Read MoreAccreditation supports company’s global expansion strategy.
Read More